Mode of action of novel acaricide pyflubumide: Effects on the mitochondrial respiratory chain

DOI Web Site Web Site 3 Citations 2 References
  • Nakano Motofumi
    Research Center, Research & Development Division, Nihon Nohyaku Co., Ltd.
  • Yasokawa Noriaki
    Development Department, Research & Development Division, Nihon Nohyaku Co., Ltd.
  • Suwa Akiyuki
    Research Center, Research & Development Division, Nihon Nohyaku Co., Ltd.
  • Fujioka Shinsuke
    Development Department, Research & Development Division, Nihon Nohyaku Co., Ltd.
  • Furuya Takashi
    Research Center, Research & Development Division, Nihon Nohyaku Co., Ltd.
  • Sakata Kazuyuki
    Research Center, Research & Development Division, Nihon Nohyaku Co., Ltd.

Bibliographic Information

Other Title
  • 新規殺ダニ剤ピフルブミドの作用機構：ミトコンドリア呼吸鎖に対する影響

Search this article

Abstract

This study aimed to determine the mode of action of pyflubumide, a novel acaricide under development by Nihon Nohyaku Co., Ltd. Because of its structural similarity to succinate-dehydrogenase inhibitor (SDHI) fungicides, its ability to inhibit mitochondrial complex II was investigated. Pyflubumide exhibited low inhibitory activity on spider mite mitochondria; conversely, its deacylated metabolite (NH-form) showed high mitochondrial inhibitory activity. Pyflubumide was quickly metabolized to its NH-form in the homogenate of spider mites. These results suggest that pyflubumide is a prodrug and that the NH-form is active. Indeed, the NH-form of pyflubumide and the OH-form of cyenopyrafen, a complex II inhibitory acaricide, act on the same enzyme; a double-inhibitor titration assay showed that the binding sites on mitochondrial complex II and/or the manners of binding of these compounds exhibit clear differences. This finding suggests that these two acaricides should be classified into different groups in terms of their mode of action.

Journal

Citations (3)*help

See more

References(2)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top